GRAIL, Inc. , a healthcare company whose mission is to detect cancer early when it can be cured, today reported business and financial results for the third quarter of ...
Ensuring quality and compliance is at the core of every successful clinical laboratory. This webinar brings together CAP ...
“Our investment in the Durham laboratory services facility reflects Alcami’s dedication to scientific excellence, innovation, and operational agility,” said Katie Schlipp, President of Laboratory ...
In addition to graduate students, the Center for Advanced Imaging Research offers educational opportunities to postdoctoral research fellows. These fellows enjoy similar access to MRI facilities.
Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results